Article
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.
The Journal of clinical investigation - 1 Apr 2003
Manuelian Tamara, Hellwage Jens, Meri Seppo, Caprioli Jessica, Noris Marina, Heinen Stefan, Jozsi Mihaly, Neumann Hartmut P H, Remuzzi Giuseppe, Zipfel Peter F
Abstract excerpt
Hemolytic uremic syndrome (HUS) is a disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Recent studies have identified a factor H-associated form of HUS, caused by gene mutations that cluster in the C-terminal region of the complement regulator factor H. Here we report how three mutations (E1172Stop, R1210C, and R1215G; each of the latter two identified in three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
